<SEC-DOCUMENT>0001628280-24-012521.txt : 20240321
<SEC-HEADER>0001628280-24-012521.hdr.sgml : 20240321
<ACCEPTANCE-DATETIME>20240321160758
ACCESSION NUMBER:		0001628280-24-012521
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240321
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240321
DATE AS OF CHANGE:		20240321

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cibus, Inc.
		CENTRAL INDEX KEY:			0001705843
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				271967997
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38161
		FILM NUMBER:		24771368

	BUSINESS ADDRESS:	
		STREET 1:		6455 NANCY RIDGE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		(858) 450-0008

	MAIL ADDRESS:	
		STREET 1:		6455 NANCY RIDGE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Calyxt, Inc.
		DATE OF NAME CHANGE:	20170504
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cbus-20240321.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:ba0b1cd8-9a6d-4e68-834f-96b2257ab54a,g:790016c1-fb32-4e36-bcb4-f72765cf5a86,d:4a5debf6220245de9c0bf78bddf70f0f-->
<html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cbus-20240321</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001705843</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cbus-20240321.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001705843</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-21</xbrli:startDate><xbrli:endDate>2024-03-21</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4a5debf6220245de9c0bf78bddf70f0f_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report: (Date of earliest event reported):  <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">March 21, 2024</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Cibus, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-38161</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">27-1967997</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:48.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">6455 Nancy Ridge Drive</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">CA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">92121</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Zip Code)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">858</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">450-0008</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.052%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of exchange<br/>on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Class A Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">CBUS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">o</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4a5debf6220245de9c0bf78bddf70f0f_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02. &#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 21, 2024, Cibus, Inc. (the &#8220;Company&#8221;) announced its financial results for the year ended December 31, 2023. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. <br/><br/>The information in Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unless the Company expressly sets forth in such filing that such information is to be considered &#8220;filed&#8221; or incorporated by reference therein.<br/></span></div><div id="i4a5debf6220245de9c0bf78bddf70f0f_10"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) Exhibits</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="cbus-20231231xpr.htm">Press Release, dated March 21, 2024</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4a5debf6220245de9c0bf78bddf70f0f_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, Cibus, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated: March 21, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CIBUS, INC.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Rory Riggs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rory Riggs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Chairman</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>cbus-20231231xpr.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i50f859760cf6409e9585f6104f65a5ef_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Cibus Reports Fourth Quarter Financial Results and Provides Business Update </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font><br></font></div><div id="i50f859760cf6409e9585f6104f65a5ef_4"></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Completed successful transfers of gene edited elite germplasm back to customers for commercialization for each of its three developed productivity traits&#58; Pod Shatter Reduction (PSR) in Canola and Herbicide Tolerance (HT1 and HT3) in Rice </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Signed collaboration agreements for trait development with multiple major seed companies, including Bayer, Loveland Products (subsidiary of Nutrien Ltd), Nuseed, and Interoc</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Reported achievement of successful greenhouse results for two different modes of action for Sclerotinia (White Mold) Resistance in Canola</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">   Reported achievement of successful 2023 field trial results for each of its developed productivity traits</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Opened industry's first standardized high-throughput end-to-end gene editing production facility to support the scaling and commercialization of Cibus' growing </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> crop and trait pipeline</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Positive vote in the EU Parliament to support new genomic techniques (NGTs) advances the gene editing era in the European Union</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Achieved major industry breakthrough with world's first successful regeneration of Wheat plants from single cells</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Raised $20.3 million of gross proceeds via registered direct offering in the fourth quarter<br><br></font></div><div id="i50f859760cf6409e9585f6104f65a5ef_10"></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SAN DIEGO, March 21, 2024 &#8211; Cibus, Inc. (Nasdaq&#58; CBUS) (the &#34;Company&#34;), </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop  plant traits (or specific genetic characteristics) in seeds</font><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, today announced its financial results for the quarter</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> ended</font><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> December&#160;31, 2023, and provided a business update. Management will host a conference call and webcast today at 4&#58;30 p.m. ET.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Management Commentary</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34;2023 was a pivotal year for Cibus, both in terms of our evolution as a public company following the merger with Calyxt and the implementation of our commercial strategy as we transformed from our research and development origins,&#34; stated Rory Riggs, Co-Founder, Chairman, and CEO of Cibus. &#34;The centerpiece of our commercialization goals are the commercial advancement of each of our three developed traits &#8212; Pod Shatter Reduction in Canola, and our two herbicide tolerance traits in Rice, HT1 and HT3. We've made significant progress on the commercial front with several advancements of these developed traits, including transfers to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">customers. We also continued the progression of our advanced traits &#8212; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> resistance, and our HT2 trait in Canola and Winter Oilseed Rape &#8212; and our efforts to extend our proprietary </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> platform to the world's major crops. Furthermore, we celebrated a key catalyst for our industry in February when the EU Parliament voted to advance new regulations that, when adopted, will treat the applications of gene editing technology like ours in a similar fashion as conventional hybridization techniques that have been in existence for centuries. This vote was a significant milestone for our entire industry and is a crucial step that will help Cibus usher in the gene editing era.&#34;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mr. Riggs added, &#34;At Cibus, we are building a leading agricultural biotech company that uses proprietary gene editing technologies to develop complex plant traits in customers' seeds to address farmers' most pressing productivity and yield challenges. We develop these productivity traits using our gene editing platform &#8211; the Rapid Trait Development System&#8482; or </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">which is the core technology driving our Trait Machine&#8482; process. Our technologies enable us to efficiently and directly edit traits into our customers' elite germplasm and form the cornerstone of our strategy to revolutionize the speed, precision, scale and range of new trait development. This is how we are leading the charge into the gene editing era. The incredible commercial momentum we have achieved so far is as strong an endorsement of our technology as it is of our ability to partner with the breeding operations of some of the largest seed companies in the world. We truly believe Cibus is at the forefront of agriculture's analog to digital moment and we are excited about our continued commercial progress in the months and quarters to come.&#34;</font><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commercial Progress</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Progress of Cibus' Three Developed Traits &#8211; Launching with Customers</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR)</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">10 seed company customers have entered into agreements to have Cibus' PSR productivity trait edited into their elite germplasm for commercialization</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Successful ongoing field trial results demonstrated a high level of PSR in seed developer genetics and achievement of the Cibus Powered&#8482;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> PSR standard</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Commenced PSR field trials for WOSR in the UK with results expected in late 2024, starting our commercialization efforts in Europe</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Herbicide Tolerance (HT1 and HT3) in Rice</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Three major Rice seed companies, including Nutrien and Interoc, have entered into agreements to have Cibus' HT traits edited traits in their elite germplasm for commercialization </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Signed collaboration agreements with multiple seed companies in North and South America to launch Cibus' HT traits in the US and Latin America, and also intend to explore new differentiated Rice traits</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Completed first transfers of customer's elite germplasm containing HT1 and HT3 productivity traits with more trait additions in progress</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Successful ongoing field trial results demonstrated a high level of HT in seed company genetics</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect to expand our current field testing of HT1 and HT3 in Rice to Latin America</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Progress of Cibus' Two Advanced Productivity Traits - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> Resistance and Herbicide Tolerance (HT2)</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Sclerotinia Resistance</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Successful greenhouse data for the first two modes of action</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect greenhouse results for a third mode of action in 2024</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Developing plan to integrate </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">resistance into Canola and Soybean once the Soybean platform is developed</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Herbicide Tolerance (HT2)</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Completed successful edits of HT2 in Canola in 2023</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect greenhouse results in 2024</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Progress on Platform Development</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Wheat Platform</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Major breakthrough with world's first successful regeneration of Wheat plants from single cells demonstrates continued success in developing scalable high-throughput breeding platforms that can operate as extensions of seed company breeding programs</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Wheat platform opens the potential to develop various productivity and sustainability traits to address the most significant challenges faced by farmers globally</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Soybean Platform</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect Soybean platform to be operational in 2024</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Development of the Soybean platform is a key moment for the development of Cibus' sustainable ingredients business</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate and Industry Progress</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Significant milestone in advancing EU gene editing regulations</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">On February 7, 2024, the EU Parliament voted to support a new proposal for the regulation of new genomic techniques (NGTs), which now moves to negotiations with the Council of the EU and the European Commission</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Proposal is expected to place Cibus' </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in a NGT1 category where it would be regulated similarly to conventional breeding </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">When adopted, this milestone would mark the opening of the market to new seed technologies and starts the gene editing era in the EU</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Opened Dedicated, High-throughput Gene Editing Facility for Trait Production</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Supports vision to change the precision, speed, and scale, and range of Cibus' growing </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> crop and trait development pipeline</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Represents the industry's first semi-automated gene editing trait production system that provides a timebound, predictable, and reproducible breeding system for the editing of commercial plants</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Raised $20.3 million of gross proceeds in December 2023</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Cibus intends to use the net proceeds to fund further development of new and existing seed productivity traits, including in Canola and Rice, Trait Machine process maintenance, research and development, working capital, and general corporate purposes</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> See &#34;About the Cibus Trait Machine</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">process and Rapid Trait Development System</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM&#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for information regarding our initial customer relationships.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Cibus Powered</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">is the i</font><font style="background-color:#ffffff;color:#333333;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">nternal Cibus trait standard that ensures each Cibus trait meets minimum efficacy and quality assurance commercial requirements.</font></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"><br></font></div><div id="i50f859760cf6409e9585f6104f65a5ef_16"></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Expected 2024 Milestones</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cibus has several important development and commercial milestone targets for 2024&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Developed Productivity Traits&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#9702;</font><font style="color:#242424;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect 8 of 10 PSR customers in Canola to have their elite germplasm edited with Cibus' trait either transferred to the customer or ready to be transferred to the customer by year end 2024</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">The transfer of an edited germplasm containing a Cibus trait to customers enables the start of a commercialization process</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expand customer base with existing developed productivity traits</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Advanced Productivity Traits&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect greenhouse results for a third mode of action for </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">resistance</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect greenhouse results for HT2</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Platform Development&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Soybean single-cell regeneration platform will be operational and have initial editing completed</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect to demonstrate initial edits toward developing productivity traits for Wheat</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Sustainable Ingredient Development&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Complete editing discovery efforts for alternative oils for CPG industry</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i50f859760cf6409e9585f6104f65a5ef_19"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fourth Quarter 2023 Financial Results</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br> <br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Cash position&#58;&#160;Cash and cash equivalents as of December&#160;31, 2023, was $32.7 million. The Company believes cash and cash equivalents will enable Cibus to fund planned operating expenses and capital expenditure requirements</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> into early in the third quarter of 2024.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.53pt">Research and development (R&#38;D) Expense&#58;&#160;R&#38;D expense was $14.2 million for the quarter ended December&#160;31, 2023, compared to $2.3 million in the year-ago period. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The increase of $11.9</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> million is primarily related to increased lab supply and facility expenses, an increase in employee headcount, and an increase in stock-based compensation expense for restricted stock award grants. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Selling, general, and administrative (SG&#38;A) expense&#58; SG&#38;A expense was $6.8 million for the quarter ended December&#160;31, 2023, compared to $1.0 million in the year-ago period. The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">increase </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of $5.8 million is primarily related to an increase in headcount, increased consulting and legal fees, and an increase in stock-based compensation expense for restricted stock award grants.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.53pt">Goodwill and intangible assets impairment&#58; Goodwill and intangible assets impairment was $249.4 million for the quarter ended December&#160;31, 2023. T</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he non-cash expense is due to the impairment of goodwill and in-process R&#38;D indefinite-lived</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">intangible assets acquired in the merger with Cibus Global, LLC completed on May 31, 2023. The Company evaluates the carrying value of goodwill and indefinite-lived intangible assets for impairment annually as of November 1 each year. The annual assessment resulted in a partial goodwill impairment of $150.4 million and a full impairment of the in-process R&#38;D indefinite-lived intangible assets of $99.0 million.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.53pt">Royalty liability interest expense - related parties&#58; Royalty liability interest expense - related parties was $8.1 million for the quarter ended December&#160;31, 2023. This is a non-cash expense.<br><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Non-operating income (expenses)&#58; Non-operating income (expenses) was income of $0.1 million for the quarter ended December&#160;31, 2023, compared to income of $0.5 million in the year-ago period. The decrease of $0.4 million in non-operating income is due to $0.8 million received in the fourth quarter of 2022 related to a settlement with one of its technology vendors regarding alleged intellectual property infringement partially offset by a $0.4 million of merger transaction costs in the fourth quarter of 2022. <br><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.53pt">Net loss&#58;&#160;Net loss was $277.2 million for the quarter ended December&#160;31, 2023, compared to $2.8 million in the year-ago period. The increase of $274.4 million in net loss was driven by the $249.4 million non-cash goodwill and intangible assets impairment. The remaining increase in net loss is described above.<br><br></font></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Net loss per share of Class A common stock&#58; Net loss per share of Class A common stock was $12.59 for the quarter ended December&#160;31, 2023, compared to $2.93 in the year-ago period. The increase of $9.66 in net loss per share of Class A common stock is primarily driven by the non-cash goodwill and intangible assets impairment which accounted for approximately $11.32 in net loss per share of Class A common stock. This is partially offset by a year-over-year increase in weighted average shares outstanding.<br><br></font></div><div id="i50f859760cf6409e9585f6104f65a5ef_22"></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Conference Call and Webcast Information<br><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cibus will host a live webcast, Thursday, March 21, 2024, at 4&#58;30 p.m. Eastern Standard Time to discuss its fourth quarter and full year 2023 financial results and provide a business update. The conference call can be accessed live over the phone by dialing (877) 704-4453 or for international callers by dialing (201) 389-0920. A replay of the call will be available through April 4, 2024 by dialing (844) 512-2921 or for international callers by dialing (412) 317-6671&#59; the passcode is 13743898.<br><br>A live audio webcast of the call will be available under &#34;News &#38; Events&#34; in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.<br><br></font></div><div id="i50f859760cf6409e9585f6104f65a5ef_25"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Cibus</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus' focus is productivity traits for the major global crops such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high throughput gene editing technology that enables Cibus to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a pipeline of five productivity traits including important traits for Pod Shatter Reduction, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> resistance, and weed management. Its initial traits for Pod Shatter Reduction and weed management are developed in collaborations with leading seed companies. Its other pipeline traits including </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> resistance are in advanced greenhouse and field trial stages.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About the Cibus Trait Machine</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">TM </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">process and Rapid Trait Development System</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">TM</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A key element of Cibus' technology breakthrough is its high-throughput breeding process (referred to as the Trait Machine&#8482; process). The Trait Machine process is a crop specific application of Cibus' patented </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Rapid Trait Development System</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8482; (</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">). The proprietary technologies in </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> integrate crop specific cell biology platforms with a series of gene editing technologies to enable a system of end-to-end crop specific precision breeding. It is the core technology platform for Cibus' Trait Machine process&#58; the first standardized end-to-end semi-automated crop specific gene editing system that directly edits a seed company's elite germplasm. Each Trait Machine process requires a crop specific cell biology platform that enables Cibus to edit a single cell from a customer's elite germplasm and grow that edited cell into a plant with the Cibus edits. Cibus has a Trait Machine process developed for canola and rice and has already begun transferring their elite germplasm with Cibus edits back to customers.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The traits from Cibus' </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-based high-throughput breeding system are indistinguishable from traits developed using conventional breeding or from nature. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> does not use any foreign DNA or transgenes. Under the European Commission's current proposals, it is expected that products from Cibus' </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> gene editing platform such as its Pod Shatter Reduction trait and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> resistance traits for Canola and Winter Oilseed Rape would be considered 'Conventional-like'.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cibus believes that </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and the Trait Machine process represent the technological breakthrough in plant breeding that is the ultimate promise of plant gene editing&#58; &#34;high- throughput gene editing systems operating as an extension of seed company breeding programs.&#34;</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Because the Trait Machine process is intended to be integrated into seed companies' breeding operations, the customer relationship between Cibus and seed companies with which it engages is a progressive relationship. Typically, the customer relationship is initiated with Cibus through the entry into a material transfer agreement pursuant to which seed companies transfer elite germplasm lines to Cibus for gene editing and delivery back to the seed company for pre-commercialization testing and validation. Accordingly, Cibus refers to seed company &#34;customers&#34; in its disclosure once such a customer relationship has been initiated. At present, all of the Company's customers discussed in this press release are at this initial stage of a relationship. While this initial stage of such customer relationships is a necessary prerequisite to the entry into a revenue generating commercial contract with such seed companies, currently, Cibus has certain customer relationships which include commercial contract terms, as well as others that are in various stages of development, including some in trait evaluation and&#47;or field testing, however these have not yet generated revenue.<br><br></font></div><div id="i50f859760cf6409e9585f6104f65a5ef_28"></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Forward Looking Statements</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This press release contains &#34;forward-looking statements&#34; within the meaning of applicable securities laws, including The Private Securities Litigation Reform Act of 1995. All statements, other than statements of present or historical fact included herein, including statements </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">regarding Cibus' operational and financial performance, Cibus' strategy, future operations, prospects, and plans, including the anticipated regulatory environment are forward-looking statements. Forward-looking statements may be identified by words such as &#34;anticipate,&#34; &#34;believe,&#34; &#34;intend,&#34; &#34;expect,&#34; &#34;plan,&#34; &#34;scheduled,&#34; &#34;could,&#34; &#34;would&#34; and &#34;will,&#34; or the negative of these and similar expressions.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">These forward-looking statements are based on the current expectations and assumptions of Cibus' management about future events, which are based on currently available information. These forward-looking statements are subject to numerous risks and uncertainties, many of which are difficult to predict and beyond the control of Cibus. Cibus' actual results, level of activity, performance, or achievements could be materially different than those expressed, implied, or anticipated by forward-looking statements due to a variety of factors, including, but not limited to&#58; Cibus' need for additional near-term funding to finance its activities and challenges in obtaining additional capital on acceptable terms, or at all&#59; changes in expected or existing competition&#59; challenges to Cibus' intellectual property protection and unexpected costs associated with defending intellectual property rights&#59; increased or unanticipated time and resources required for Cibus' platform or trait product development efforts&#59; Cibus' reliance on third parties in connection with its development activities&#59; challenges associated with Cibus' ability to effectively license its productivity traits and sustainable ingredient products&#59; the risk that farmers do not recognize the value in germplasm containing Cibus' traits or that farmers and processors fail to work effectively with crops containing Cibus' traits&#59; challenges that arise in respect of Cibus' production of high-quality plants and seeds cost effectively on a large scale&#59; Cibus' dependence on distributions from Cibus Global, LLC to pay taxes and cover its corporate and overhead expenses&#59; regulatory developments that disfavor or impose significant burdens on gene-editing processes or products&#59; Cibus' ability to achieve commercial success&#59; commodity prices and other market risks facing the agricultural sector&#59; technological developments that could render Cibus' technologies obsolete&#59; changes in macroeconomic and market conditions, including inflation, supply chain constraints, and rising interest rates&#59; dislocations in the capital markets and challenges in accessing liquidity and the impact of such liquidity challenges on Cibus' ability to execute on its business plan&#59; risks associated with the possible failure to realize certain anticipated benefits of the Merger Transactions&#59; the effect of the completion of the Merger Transactions on the Company's business relationships, operating results, and business generally&#59; the outcome of any litigation related to the Merger Transactions&#59; the Company's assessment of the period of time through which its financial resources will be adequate to support operations&#59; and other important factors discussed in the &#34;Risk Factors&#34; section of Cibus' Annual Report on Form 10-K which is being filed with the Securities and Exchange Commission (the &#34;SEC&#34;) on </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">March&#160;21, 2024</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Should one or more of these risks or uncertainties occur, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. Cibus' assessment of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves such risks and uncertainties. Accordingly, the Company could use its available capital resources sooner than it currently expects.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition, the forward-looking statements included in this press release represent Cibus' views as of the date hereof. Cibus specifically disclaims any obligation to update such forward-</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">looking statements in the future, except as required under applicable law. These forward-looking statements should not be relied upon as representing Cibus' views as of any date subsequent to the date hereof.<br><br></font></div><div id="i50f859760cf6409e9585f6104f65a5ef_31"></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">CIBUS CONTACTS&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INVESTOR RELATIONS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Karen Troeber<br>ktroeber&#64;cibus.com<br>858-450-2636</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Jeff Sonnek &#8211; ICR </font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">jeff.sonnek&#64;icrinc.com<br><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">MEDIA RELATIONS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Colin Sanford<br>colin&#64;bioscribe.com<br>203-918-4347</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i50f859760cf6409e9585f6104f65a5ef_34"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CIBUS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(In Thousands, Except Par Value and Share Amounts) </font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">As of December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Assets</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">32,699</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">3,427&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Restricted cash</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">99&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Accounts receivable</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">530</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,991</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">606&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total current assets</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">35,220</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">4,132&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Property, plant, and equipment, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">15,775</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">4,516&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Operating lease right-of-use assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">21,685</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">13,615&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Intangible assets, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">35,411</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">158&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Goodwill</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">434,898</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other non-current assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,422</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total assets</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">544,411</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">22,421&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Liabilities, redeemable noncontrolling interest, and stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accounts payable</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">6,127</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">340&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accrued expenses</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,747</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">173&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accrued compensation</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">3,858</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">107&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Due to related parties</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">175&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Deferred revenue</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,210</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">107&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Current portion of notes payable</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">833</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current portion of financing lease obligations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">187</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">97&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Current portion of operating lease obligations</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">5,927</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">367&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Class A common stock warrants</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,418</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">291&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other current liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">16</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total current liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">21,323</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,662&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Notes payable, net of current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">536</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Financing lease obligations, net of current portion</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">113</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Operating lease obligations, net of current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">17,025</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">13,447&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Royalty liability - related parties</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">165,252</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other non-current liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,868</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">79&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">206,117</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">15,188&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">As of December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Redeemable noncontrolling interest</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">44,824</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Stockholders&#8217; equity&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Class A common stock, $0.0001 par value&#59; 210,000,000 shares authorized&#59; 21,240,379 shares issued and 20,567,656 shares outstanding as of December 31, 2023, and 275,000,000 shares authorized&#59; 978,915 shares issued and 976,908 shares outstanding as of December 31, 2022</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Class B common stock, $0.0001 par value&#59; 90,000,000 shares authorized&#59; 3,142,636 shares issued and outstanding as of December 31, 2023, and no shares authorized&#59; and no shares issued and outstanding as of December 31, 2022</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Additional paid-in capital</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">775,017</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">220,422&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Class A common stock in treasury, at cost&#59; 32,663 shares as of December 31, 2023, and 2,007 shares as of December 31, 2022</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(1,785)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(1,043)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accumulated deficit</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(479,778)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(212,151)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Accumulated other comprehensive income</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total stockholders&#8217; equity</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">293,470</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">7,233&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Total liabilities, redeemable noncontrolling interest, and stockholders' equity</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">544,411</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">22,421&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i50f859760cf6409e9585f6104f65a5ef_37"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CIBUS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(Three Months Ended December 31 Unaudited) </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(In Thousands, Except Share and Per Share Amounts) </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Three Months Ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Year Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Revenue&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,103</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">42&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,817</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">157&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Total revenue</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,103</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">42&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,817</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">157&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">14,208</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2,346&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">42,367</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11,553&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">6,788</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,009&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">28,914</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,974&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Goodwill and intangible assets impairment</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">249,419</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">249,419</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total operating expenses</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">270,415</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,355&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">320,700</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">22,527&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Loss from operations</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(269,312)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3,313)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(318,883)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(22,370)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Royalty liability interest expense - related parties</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(8,139)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(18,892)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other interest income (expense), net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">168</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(7)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">527</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(87)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-operating income (expenses)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">71</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">483&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(395)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5,566&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Loss before income taxes</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(277,212)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2,837)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(337,643)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(16,891)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income tax benefit (expense)</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net loss</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(277,208)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2,837)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(337,639)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(16,891)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net loss attributable to redeemable noncontrolling interest</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(60,094)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(70,012)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net loss attributable to Cibus, Inc.</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(217,114)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2,837)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(267,627)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(16,891)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Basic and diluted net loss per share of Class A common stock</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(12.59)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2.93)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(25.95)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(18.36)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted average shares of Class A common stock outstanding &#8211; basic and diluted</font></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">17,244,665</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">968,871</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">10,314,554</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">919,959</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i50f859760cf6409e9585f6104f65a5ef_40"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CIBUS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(In Thousands) </font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:75.304%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.656%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Year Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Operating activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(337,639)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(16,891)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Adjustments to reconcile net loss to net cash used by operating activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Royalty liability interest expense - related parties</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">18,892</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Goodwill and intangible assets impairment</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">249,419</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">4,693</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,534&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock-based compensation</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">16,092</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,998&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Loss on disposal of property, plant, and equipment</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">224</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Change in fair value of liability classified Class A common stock warrants</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,127</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(5,120)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Changes in operating assets and liabilities, net of acquisitions&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts receivable</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,704</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Due to&#47;from related parties</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(95)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,150</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">389&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(229)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accrued expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(2,065)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(166)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accrued compensation</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">891</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2,415)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred revenues</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(89)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(56)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets and lease liabilities, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(106)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">199&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets and liabilities, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(431)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(610)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash used by operating activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(46,210)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(19,364)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash acquired from merger with Cibus Global, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">59,381</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchases of property, plant, and equipment</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(4,321)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1,520)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net cash provided by (used in) investing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">55,060</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1,520)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Financing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds from Class A common stock and pre-funded warrants issuance</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">20,306</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11,538&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Costs incurred related to the issuance of Class A common stock and pre-funded warrants</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(1,550)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1,173)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Proceeds from draws on revolving line of credit from Cibus Global, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2,500</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Payment of taxes related to vested restricted stock units</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(742)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Proceeds from issuance of notes payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,378</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Repayments of financing lease obligations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(297)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(376)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Repayments of notes payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(1,275)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash provided by financing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">20,320</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9,989&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Effect of exchange rate changes on cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net increase (decrease) in cash, cash equivalents, and restricted cash</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">29,173</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(10,895)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash, cash equivalents, and restricted cash &#8211; beginning of period</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">3,526</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">14,421&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash, cash equivalents, and restricted cash &#8211; end of period</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">32,699</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,526&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cbus-20240321.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:ba0b1cd8-9a6d-4e68-834f-96b2257ab54a,g:790016c1-fb32-4e36-bcb4-f72765cf5a86-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cbus="http://www.cibus.com/20240321" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cibus.com/20240321">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cbus-20240321_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cbus-20240321_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.cibus.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cbus-20240321_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:ba0b1cd8-9a6d-4e68-834f-96b2257ab54a,g:790016c1-fb32-4e36-bcb4-f72765cf5a86-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_d43ebee3-5c09-4deb-82ff-eb187d12872c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a2eab97e-4a04-423c-9fa5-a24aa25c2706_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_23275836-df28-40de-837d-eab0ac2fc9ec_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_eb8ec839-35aa-4c36-b0b3-29fd932b6e54_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_7738ad4a-f814-4ab3-91db-ad5f7dc22bd1_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_56775788-2917-4854-b812-03bda8ee9561_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3d0c440d-9331-458b-acea-9aa62a3e7553_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_74d07388-1606-4a07-8a2d-5fe630ef08c4_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_85ace912-dbb1-4573-9d1f-78af81fc4868_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ffbaf944-e838-4467-898d-4490c032f6f6_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_a32e17ef-eceb-4d7c-aa61-3d7f958226f7_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_a3e28589-ba86-4743-b3f5-adb8b59a3400_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_3d144f6e-872e-40ad-8f53-d4f2849c501e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9d82b257-a740-4541-a015-858b6d46c10f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6f6ef9ed-85d9-4e57-b67d-3221a2f72217_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5d69a6d5-28ce-490f-9e87-257cffb0df40_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_461a6332-8022-4099-830f-a509a080310c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_49ee7f66-efdb-4b38-ab06-e225d8e6d7a5_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_16aa096c-5513-4355-abdc-4e5b9f5e0e4d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f85727d3-b39b-4077-a821-131122770db1_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_2a382b5d-bf0f-46bb-aa94-1aa06f126c81_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6a2d4597-51ac-4bef-8d43-abded8f8426d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cbus-20240321_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:ba0b1cd8-9a6d-4e68-834f-96b2257ab54a,g:790016c1-fb32-4e36-bcb4-f72765cf5a86-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cibus.com/role/Cover" xlink:type="simple" xlink:href="cbus-20240321.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.cibus.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5b900106-e122-426c-bba2-2185be7aac64" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_DocumentType_5b900106-e122-426c-bba2-2185be7aac64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4b0cc38f-c7c5-4397-8f00-2fd15ace2943" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_DocumentPeriodEndDate_4b0cc38f-c7c5-4397-8f00-2fd15ace2943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f7346d71-62a6-44d9-b3f8-0ef92b7d302f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_EntityRegistrantName_f7346d71-62a6-44d9-b3f8-0ef92b7d302f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_5fa1e20c-abda-4737-910d-a0712dc7b32e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_EntityIncorporationStateCountryCode_5fa1e20c-abda-4737-910d-a0712dc7b32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a22743e3-2393-4965-9b2a-9335f76fb59a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_EntityFileNumber_a22743e3-2393-4965-9b2a-9335f76fb59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_39a50af8-245f-494d-b1b9-c202c2708e90" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_EntityTaxIdentificationNumber_39a50af8-245f-494d-b1b9-c202c2708e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7bb19394-4434-4eab-acaa-bcb911da53d0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_EntityAddressAddressLine1_7bb19394-4434-4eab-acaa-bcb911da53d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_4e371a68-f9bf-486f-8c2a-e9602348fe89" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_EntityAddressCityOrTown_4e371a68-f9bf-486f-8c2a-e9602348fe89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6b99b15c-2f5b-43e8-89f0-6931ded8afbe" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_EntityAddressStateOrProvince_6b99b15c-2f5b-43e8-89f0-6931ded8afbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_de197c22-0095-462e-9f02-c2c70ca4c3e8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_EntityAddressPostalZipCode_de197c22-0095-462e-9f02-c2c70ca4c3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6cc5b6be-991e-46ce-97dd-e5caa1a8a0d0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_CityAreaCode_6cc5b6be-991e-46ce-97dd-e5caa1a8a0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_56c6ef9a-ca3e-4486-9cd1-c87ff8e549cf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_LocalPhoneNumber_56c6ef9a-ca3e-4486-9cd1-c87ff8e549cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_7fdf5964-fa79-4035-a8da-d1b2e127d861" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_WrittenCommunications_7fdf5964-fa79-4035-a8da-d1b2e127d861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_a2a17f2e-03fd-4525-b1ec-b799d167c70a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_SolicitingMaterial_a2a17f2e-03fd-4525-b1ec-b799d167c70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_235c65aa-bc96-4a8e-b0ce-77e8fffe976f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_PreCommencementTenderOffer_235c65aa-bc96-4a8e-b0ce-77e8fffe976f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_92f254f1-45ea-4260-8c19-60aef21905c3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_92f254f1-45ea-4260-8c19-60aef21905c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8806c99c-1e4f-4a65-86a0-7a6df24b1a74" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_Security12bTitle_8806c99c-1e4f-4a65-86a0-7a6df24b1a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8df92c8e-8112-44de-80e3-7783b9c6fff4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_TradingSymbol_8df92c8e-8112-44de-80e3-7783b9c6fff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_afe7f518-2ee2-434b-8222-8c0242ba1e37" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_SecurityExchangeName_afe7f518-2ee2-434b-8222-8c0242ba1e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8cfa2fcf-e6c4-4170-9025-a9f7030989c1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_EntityEmergingGrowthCompany_8cfa2fcf-e6c4-4170-9025-a9f7030989c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_692b48f0-ba8f-49be-95a8-6b4629171afb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_EntityCentralIndexKey_692b48f0-ba8f-49be-95a8-6b4629171afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b13f85e4-dc3b-4409-acf4-35dc594ae88e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_789ddaf3-35d9-45b8-ad8f-1de2b6c15501" xlink:to="loc_dei_AmendmentFlag_b13f85e4-dc3b-4409-acf4-35dc594ae88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>cibus_logoxrgb.jpg
<TEXT>
begin 644 cibus_logoxrgb.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X )D%D
M;V)E &3      0, %00#!@H-   K#   .O0  %U-  ""./_; (0 !@0$! 4$
M!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,# P,# P0# X/$ \.#!,3%!03$QP;
M&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?_\( $0@!)P3" P$1
M  (1 0,1 ?_$ /(  0 # 0$! 0             %!@<$ P(! 0$! 0$! 0$
M            !00# @$&$  ! @0% P0" @$% 0     # 0( $ 0%(#! $3$R
M$P8A$C0U4!1P,Q9@(B,5)201  $" 00-"@4# P,#!0    $" P @$2$Q,$!!
M47&QP1(B,E)R!&&!D:'1X8(3(S,00F*2LE"B%'#Q4V#P--)#8W.#DZ,D$@ "
M  0' 0$            1(4!08'  $" P@) !,: 3 0 ! @()! ,! 0$
M  $1 #$@(3! \$%187&AL1"!D<%0T>'Q<&#_V@ , P$  A$#$0   =4
M             'SY!8<41DQ^?GSW=^]BH4>CKT
M                                                   K,R9 3\
M]??JZ6K79V[
M                       "@P('AS\ >_3WU=>OCX\7FY<_?OT
M
M  "DQ(G!GX 3V_?9:5&A085EITIK;M
M                                          Y./&H2)')QY='3I<[5
MGJZ]:O+E\_/G<+%@
M                            #S\^?3UZ A<.*O3Y][O70
M
M   (G'DJ\R7?K]\
M                         "*R9(W-F[>_>7UZ_OUZ $%@P0F+%>+EP
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MTY^WG[X^GCK\>_OY]^_BX8=H  $1WXYK5F1'?B     /OY]UN)7FN'<
M "!P8*Q+F"8V;+;7K<O'C1(4.^W[W1TZ      "-Z\L9O10   /3Y]T271N&
M':        !DMJ1 Z<X&O1+$UG[@   "G[L6;U9H%UP;M#ET0      !7=6;
M+[$OQ^^0   +%ETZE'J^GSZ  ,UK3+W-WT.E/T.72S2M,TZ13RZQ+U:-6  %
M3VX\WJS?/[\      &KQJUARZ0      (?'CJ4B2/WZOU^_"XL4-BQWF[<
M     C>O+&;T4    ?IIDBI:\>L        9+:D0.G.!KT2Q-9^X    I^[%
MF]6:!=<&[0Y=$      ")[<<BN1_+[\     M>/7ILBH  ,QKR]#ET<\J3OQ
M\FL_>ZX-V36I&LQ:X %.W8LYJS?P $CRZ6K'KF\_?NY]/OXY/?F'[\*SKS06
MG/\ @-7C5K#ET@      1&/'49$D"V5JT#@P2>K39*5(      "-Z\L9O10.
MOQ[MV+7\'!UYU[3G\?7D#H\^MG@VNGQ[        R6U(@=.<#7HEB:S]P
M!3]V+-ZLT"ZX-VARZ(      &2VY$#HS@?3[<L&RT8]?7X]<73Q4-V.J;,@
MU6-6L>72 !4-V,0>CAH\JEFE:7;<6R#T<+]-H "NZLV5V9/R ='GUH4NC;<6
MO]?0  (GMQSZI.KVG/J\:M8<ND      "(QXZC(D@2^S7$8\EXN6^WOW
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M\=1D20!.[]UHJ5       !&]>6,WHH$OQ[;#"L@ 8[=C1/;B/7Y]W/\ .W@
M      ,EM2('3G UZ)8FL_<    4_=BS>K- NN#=H<NB      *GMQYG6F 6
MC)JU"/5            CNO+&KT7Y!^FK1JUARZ0             !$8\=1D2
M0!;Z]>6V:P      !&]>6,WHH$OQ[;#"L@ 9';CP>C@/HW;\Y?        R6
MU(@=.<#7HEB:S]P   !3]V+-ZLT"ZX-VARZ(      @-.?)K4@#J\>]G@VO?
MSZ           &?TYU'H80+)ETZI&K               1&/'49$D 7Z_>]^
MG0       1O7EC-Z*!+\>VPPK( &)_H(?'[\"0Y]-H@6P       ,EM2('3G
M UZ)8FL_<    4_=BS>K- NN#=H<NB      //[\Q+]!#\/7D";S]]/D5.[G
MT           QJ]%C.O(#5XU:PY=(              $1CQU&1) ]??K0/T'
MZ        "-Z\L9O10)?CVV&%9 %:UY<LL2@+G@VZ++I        9+:D0.G.
M!KT2Q-9^X    I^[%F]6:!=<&[0Y=$      "B4<%"I3P!Z_/MKQ:[E@VRW'
ML         .?UYQ#]#"_ >OS[N/YZ[]?/H              $1CQU&1) []'
M>[6[8       $;UY8S>B@2_'ML,*R.?UYJVS)G].?X>O(]OGK9(-GNY]
M    ,EM2('3G UZ)8FL_<    4_=BS>K- NN#=H<NB      !\OF6V95;U9@
M !-Y^]RP[;3BU?3Z       !#=^&07(X$SP[:_#L@              "(QXZ
MC(D@2VO5;[%@       "-Z\L9O10/M]Z?'KS^_/#UY_ #]-1CU;-DU
M  #);4B!TYP->B6)K/W    %/W8LWJS0+K@W:'+H@      #Y^_,]ISJ9OQ?
M@  )#GTT*71LV34       *YJS959D@63+IU2-6               $1CQU&
M1) F=NRV5JP       $;UY8S>B@    2_'MH<NC/9M        &2VI$#IS@:
M]$L36?N    *?NQ9O5F@77!NT.71        $+WX4.E@KVK-^   M^'9H\JE
M]/H      KFK-E5F2!9,NG5(U8               1&/'49$D":V[;76J@
M     1O7EC-Z*     /HTB33MV+8       ,EM2('3G UZ)8FL_<    4_=B
MS>K- NN#=H<NB         (WKRIN_%4MN3P]>0 +9BUZ9)J      "$T<,BM
MQP)GAVU^'9               $1CQU&1) FMNVUUJH       $;UY8S>B@=W
M/I>IVX?/UR^_$/WXU_3G\_OP#[?==AV)CAV       R6U(@=.<#7HEB:S]P
M  !3]V+-ZLT"ZX-VARZ(          \?7FF;\5&HX?'[Y &IQZMER:@
M.3WXQ+]!# ]?GW<?SUWZ^?0              (?%CJ4F2!-;=MKK50
M (WKRQF]% E^/;885D #BZ<\ML2H;OQ L&;1K$6N      !DMJ1 Z<X&O1+$
MUG[@   "G[L6;U9H%UP;M#ET0          !&]>63VI/#TY@3N?OK<2P
M  ,6OQ.#IS U:-6L672              !"XL54DR@)K;MM=:J       !&]
M>6,WHH$OQ[;#"L@ #C]^,9OQ?'[Y'Z;9^?N=?CV      ,EM2('3G UV)8F\
M_<    4S?BSJI- NN#=H<NB           ! :<^36I 'T^[C^=N>OST
M!G-6;3=V("QY=.JQJP              $+BQ523* FMNVUUJH       $;UY
M8S>B@2_'ML,*R  !E]B55]>4#5XU:PY=(      RFS)KNK,!J4>K9LFH
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M6   /Q\Q']##YO7D#;OS]SJ\>P     !P].>.78WAZ\@=OCWJD:M+\.P
M\OOG-ZTVV8M=ARZ0      (C'CJ,B2!-;=MKK50       (WKRQF]% E^/;8
M85D  0&G/D]J1^ _3;?S]SJ\>P     !Q^_&*_H(GR^ :C(JV?'J   % ISZ
M-0P =_/IM,"V      (SMRQJ[% ^GW:(%KNY]  !6M>7++$H#NY]-J@6P
M   !6=>7+K$K\ /3Y]O,[?=<&WV\^@  *SKRY[4G1_3GJ\:M8<ND      ".
MS9J7%C 36W;:ZU4       "-Z\L9O10)?CVV&%9 'E]\U/;DSZG/\?7D"Q9=
M.K1JP       S2M,J6W&![?/NFR*EER:@ !1Z&"@4Y_X :-+I7+!M
MQZ[&B.W$"<S]]6C5O;SZ $;UY9+;D<?OP!=Y^[09E$       "G;L6<U9OX
M#W\^K)DTSF?OW<^GT<_KS$]N59V98SKR U>-6L.72      !Y^/&?P('Y\":
MV[;76J@       1O7EC-Z*![?/4QG[#\^_.?UYC>O/X^_ !Z?/NO0[$MQ[
M     #E]^,=NQN/WX _2?S:+-DU2'+I\D7VXU7;EB>W$ 3>?OKD2O^OH
M  %8UY<NL2@!W\^EPP[);AV^?OR"T<*?NQ^/KR!T>?6RP;77X]@       "K
M[,F:UIGC]^      #5XU:PY=(       I<2+'9\XFMNRUUJP       $;UY8
MS>B@    #Z?=,D4[5CU@       "&[\,HM2>?UY     $ERZZW$K]?CV
M   !E]>55]F4    #Z-/CU;/DU         ".Z\LXJS:_IS@    #L\>]8BU
MY3CU       $3DR5"/($GJTW*S9        C>O+&;T4    #M\>])DT[%ET@
M        "*[<<OL2XSKR    %AS:-.D5.GQ[        'G]^9A7E5K7F
M]?GW2I-.TX]8          $#IST_=CK>K-X^O(  ^GV<S=[9BUVK'K]/GT
M      5"/(B<F3[]?;U=N]'3H       (WKRQV[&  'T>OGUV>/<GQZV#-HM
M.+5Z_/0          ^/ORE[\5-WXN#IS  $QP[7:?NM6/6          *CMQ
MT:C@CNO, #[^?;-DTWZ;0D>74            ?+Y%=^4;UY<WOS\G1Y^]_+I
M+\>WMY]          ?'GS594J'QY/7WZE]>RTU:@
M     $7VXQ/;ES>_/Z=G/W,<.W=SZ            "*[<8GMRY_?GZ^._GTF
ML_?H\^@                            (S+EC,V;T]>K%1H@
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M.0RD&M-<*A3?E2VNWEA_CE L+XQ3PGC--#/'K<V T-&'5FM=O-#_ !N@6/\
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MYA\5%I/>'\1(8P'&;&UOY#(>W1CL\VTL#+DD-).JG2/-+*32#01"L]<W#SZ
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M )C^%,Y.>U#V+4RA;<RQSO.]6R<;;%I,_P!U#3%NPCO-/(W%>'W@@/@O+Z_
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MDDDEVT>DDDDDDDB__P#_ /\ \DDDDDDDDDW_ +))))(_^)))))))) /_ /\
M_P#I))(,UFI))&O_ /\ _P#_ /\ ,DDDDDDD&UD4DDDDDDD7_P#_ /\ [TDD
MDDDDDDF_]DDDDD?_ !)))))))&?_ /\ _P#^)))!@^/)).__ -FR[Y_F2222
M222';;62222222+_ ..&_P"C))))))))-_[))))(_P#B2222222#_P NHO\
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M !))))))).?_ /\ 0\DDDDDDDD?_ ')))))))))))))))(=LY)))))))(O\
M@E_^J222222223?^R2222/\ XDDDDDDDD+__ /\ U22222222;_F22222222
M22222220[:R22222221?_P#_ /\ \622222222;_ -DDDDD?_$DDDDDDDDG3
M_P#_ -.2222223?^R222222222222222';:22222222+_P#_ /\ _P#.DDDD
MDDDDW_LDDDDC_P"))))))))))%=__P#R222222#_ -DDDDDDDDDDDDDDDD.V
MTDDDDDDDD7_3<-7_ !))))))))O_ &22221_\222222222226C_\R222221?
M^F222222222222222+;:22222222+_B22%_^R2222223?^R2222/_B222222
M222221K_ -DDDDDDD7_LDDDDDDDDDDDDDDDNVTDDDDDDDD7_ !)))A_]))))
M)))O^)))))%_Y))))))))))))%_QY))))))/^I)))))))))))))))=MI))))
M)))(O^)))(?_ &2222221?\ \DDDDF_^DDDDDDDDBDDDD/\ ]))))))(_P#^
M222222222222222[;222222221?\2223_P#LDDDDDD@_ZDDDDDW_ /))))))
M%6I))))/_9))))))%_[Y))))))Y)))))))=MI)))))))(O\ B222;_V22222
M21_^R2223[_B222222/_ -DDDG/_ +))))))(M_R)))))'3)))))))#MM)))
M)))))%_Q))(G_;)))))))I_Q)))(/_!))))))!_XI))+_P#22222222*_P#>
MLDD@QYDDDDDDDGVVDDDDDDDDB_XDD_W_ %))))))))/^3)) W_Q)))))))!_
M[9)/?_Y)))))))([_P#[M%X?\R2222221G;222222221?^;5[_\ 7DDDDDDD
MD)_[L&X__P Y))))))(O_P 57;_I222222222$__ /\ _P#_ /YDDDDDDDD6
MQDDDDDDDDB__ /\ _P#_  I)))))))).O_\ _P#_ /XI))))))))_P#_ /\
M_P#G2222222222,__P#_ /\ _P!DDDDDDDDDVLDDDDDDDD7_ /\ _P#_ #9)
M))))))))*/\ _P#_ /R9))))))))(_\ _P#_ /;)))))))))))*M_P#_ ,VD
MDDDDDDDDFQDDDDDDDDG_ /\ \X >222222222202?_\ _P")))))))))) O_
M /\ 3,DDDDDDDDDDDDC#&?LDDDDDDDDDD[U4DDDDDDDDDDDDDDDDDDDDDDDD
MDD/$5DDDDDDDDDDDDD^7&DDDDDDDDDDDDDDDDDDDDDDDDDDDDDA-DDDDDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDG_V@ ( 0$# 3\0
M_"NG *C !=6B"Y15)\A]%33E#A[QY5+ 9G,#X"5N\=1U,L_2FZ5K)7=]EO\
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M46=?JB/A@9L1[[*_"B@%MUG6#[U+9_'I(783*YP"S[Y1"V)"2-W)]L#RC/\
M,=.C("Y\,C$2WV&?!*:N,'#Q9W.B!QI%(0F2-QQY9"SA=TW2X7-W"@\@0 $B
M%QTXL,1G.1@,NISWA"E^7*(VS^/2G_(@H)$3,1IR L$!,^1,^3._YGIT9 Z,
MVR]XY63A(J*T9D9\CS:-CJRVAOED.9EBF!PW];+O;-SU3IF+,FL3$KV6!$(/
M?0N_Y<HC;/X\!@O1$1%D@F[U,,==S-!1T*"B!=T/O*9T)EDATT>0:2VT*ES
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MEG1 %M_2@ EG_B2IP<SWP3\*1\T+*S2*]S4@[^#_ ,2@;?<TUDRX[O1&!^J
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FNXCQXI=D5SU&\7:MW3U:L8/SC><=0-;J3W_BCTA.1E?Y?_7?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140461607652640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 21, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 21,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cibus, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-1967997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6455 Nancy Ridge Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">450-0008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CBUS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001705843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M]P#<7REEWP=NUUK^TV'\'U!+ P04    " #\@'58GZ ;\+$"  #B#   #0
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M?P%02P$"% ,4    " #\@'58!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( /R =5CEN%J*[P   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( /R =5B97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ _(!U6)L!]MY'!   @!   !@
M         ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( /R =5B?H!OPL0(  .(,   -              "  8L,  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ _(!U6)>*NQS     $P(   L
M ( !9P\  %]R96QS+RYR96QS4$L! A0#%     @ _(!U6*K$(A8S 0  (@(
M  \              ( !4!   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M /R =5@D'INBK0   /@!   :              "  ; 1  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /R =5AED'F2&0$  ,\#   3
M              "  942  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(  -\3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cbus-20240321.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cibus.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="cbus-20240321.htm">cbus-20240321.htm</File>
    <File>cbus-20240321.xsd</File>
    <File>cbus-20240321_lab.xml</File>
    <File>cbus-20240321_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cbus-20240321.htm": {
   "nsprefix": "cbus",
   "nsuri": "http://www.cibus.com/20240321",
   "dts": {
    "inline": {
     "local": [
      "cbus-20240321.htm"
     ]
    },
    "schema": {
     "local": [
      "cbus-20240321.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cbus-20240321_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cbus-20240321_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.cibus.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cbus-20240321.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cbus-20240321.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001628280-24-012521-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-012521-xbrl.zip
M4$L#!!0    ( /R =5@O8[UW3SX  #LJ P 4    8V)U<RTR,#(S,3(S,7AP
M<BYH=&WM?>MSXLB2[_?[5]3MF3OMCA <)-[VG([PN-TSWNW7VIZ=V$\G"JD
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M]LWW[FQ@0_8;LJ0( O;GW (69=',=S-^8ZWQLT)R;[A(Z^V"3MXN>+DUC&E
M3SJU0[C<S%"ED[^JWFSN")0:P<(T88G&"X>%/KQC+/R >6,V$:Y@PK+Q&N'
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M\Q"=$H0;0_2ATQ/Y? Z$5M>G_6 9-6;)'/N[P '26<3AO %:(M[@P52A"=C
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MR64,#.&("2:>"RF/7D+8["F"9S,Q\0)+^<I0R^^>9Q'NIK;H;LC=">7N\"#
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M.RK#1SUIL5UX),$:,7H@KA,RGH5M<Z>4ZX.FOJU45RW<^8J<;>Y'<S@8NJL
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ME"+U]V,+*"]?WQ)QBMF&N$H:=E74<F0<E NJ0L,HZ3X(%K.Y_#MQ8Z?CRRA
M2&T "FH&-E=9(>FWQ$@P%3*=:HE'7L>G!QTL1G^K(L'N G A CS?#K[+P2Y<
M!2U# I\SA/\PZ&0TEHT]P4!MQP>HYKUTYT@L/64Q()3I.?%LXV!2+A-153:
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M;V'T.% D@ ,5G?AD=5WX,%B*[D>]NA'[8.3""%JV+'NL<J$2PFE+ N ?%>F
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M0]&RT)E3XYO]DOV;+^;<3E((4L' 9L;8<1S(1]>&0[W\0JG&/?M9EEZK]TJ
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MJ+5[G9(MYN&;'>^]X/>5>R>"74BK=8_;-9[Q]"(_Y^D'&.%."\F7L7SG!1Z
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M4F_95L>5G9ZFB>V3G&GGOG1 $I304"0/ &WK?OWM@J0>EF1+B6/);CJ=1"1
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MM1<\$K/+PUJY8&F;D948OTAF>M_(<,ZD)WBB#R1^W=;[T[FX;3?EOWJ>;W&
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M[Q47:H_LI7JQ DK&F1NWT/TBA ]?"(P<ZRQXB7VATBHHOO&E.[^\TH[<0?Y
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M#:R]AIIT[1]HCUC5J"\N;_),?KY;<EG,)*<RH4$, \(8Q$EU%.'Q *)8B3A
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MRIA(!F/&0L0"&1$2V%'?+30.[AOMQH3>ZMM"WE,N4[J'%\$):P?_#C#O-S>
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M,C,Q>'!R+FAT;5!+ 0(4 Q0    ( /R =5A-<79/_PX  %=G   1
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64$L%!@     %  4 1@$  %=A      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>cbus-20240321_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cbus-20240321.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001705843</identifier>
        </entity>
        <period>
            <startDate>2024-03-21</startDate>
            <endDate>2024-03-21</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001705843</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-03-21</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Cibus, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-38161</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">27-1967997</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">6455 Nancy Ridge Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">450-0008</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Class A Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">CBUS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
